Patient Registry Software Market: Growth, Size, Share, and Trends
Patient Registry Software Market by Disease (Diabetes, Cancer, Rare, Asthma, Kidney), Product (Drugs, Device), Use Case (Population Health, Research), End User ((Profit: Pharma, Payer, Hospital), (Non-Profit: Govt)) & Region - Global Forecast to 2030
USD 3.61 BN
MARKET SIZE, 2030
CAGR 9.9%
(2025-2030)
250
REPORT PAGES
380
MARKET TABLES
OVERVIEW
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
The global patient registry software market is projected to reach USD 3.61 billion by 2030, up from USD 2.25 billion in 2025, growing at a CAGR of 9.9% during the forecast period. The robust market growth is fueled by the increasing focus on patient-centric care and the shift toward value-based healthcare delivery.
KEY TAKEAWAYS
- The Asia Pacific is expected to grow at the fastest CAGR of 11.4% driven by rising incidences of diabetes, cardiovascular disease, and cancer, which spurred national efforts to implement disease-specific registries, such as the National Cancer Registry Programme and the Registry of People with Diabetes, supported by public-private partnerships.
- The site-based/clinical data (provider-recorded) registries segment accounted for largest share of 65.1% in 2024
- Key use cases such as medical research & clinical studies and quality improvement are increasingly utilizing patient registry software due to the rising emphasis on real-world evidence generation and growing demand for post-marketing surveillance
- Disease registries segment is expected to grow at a CAGR of 10.1%
- The cloud-based deployment model is expected to register highest CAGR of 12.2% due to the growing need for interoperable systems, rapid implementation of updates, and reduced reliance on on-site IT infrastructure.
- Profit registries are witnessing growing demand for patient registry software due to the rising demand from pharmaceutical, biotechnology, and medtech companies seeking robust real-world data for regulatory submissions, market access, and post-market surveillance.
- IBM, IQVIA, Health Catalyst were identified as some of the star players in the Patient Registry market (global), given their strong market share and product footprint.
- Verana Health, Pulse Infoframe Inc., Amplitude Clinical Outcomes among others, have distinguished themselves among startups and SMEs by securing strong footholds in specialized niche areas, underscoring their potential as emerging market leaders.
The patient registry software market was valued at USD 2.07 billion in 2024 and is projected to reach USD 2.26 billion in 2025 to 3.61 billion by 2030, at a CAGR of 9.9% during the forecast period.
TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS
The impact on consumers' businesses stems from customer trends or disruptions. Hot bets are the clients of patient registry software manufacturers, and target applications are also clients of these manufacturers. Changes, whether trends or disruptions, will influence the revenues of end users. This revenue impact on end users will, in turn, affect the revenue of hot bets, which will further influence the revenues of patient registry software manufacturers.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
MARKET DYNAMICS
Drivers
Impact
Level
Level
-
Growing demand for real-world evidence (RWE)
-
Rising burden of chronic and rare diseases
RESTRAINTS
Impact
Level
Level
-
Data privacy and security concerns
-
Shortage of trained and skilled resources
OPPORTUNITIES
Impact
Level
Level
-
Integration with AI and analytics tools
-
Expansion of population health management and outcomes tracking
CHALLENGES
Impact
Level
Level
-
Inconsistent data quality and completeness
-
Limited awareness among healthcare stakeholders
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
Driver: Growing demand for real-world evidence (RWE)
The need for real-world evidence (RWE) in regulatory decision-making and value-based care is driving increased use of patient registry software. Disease-specific registries for chronic and rare conditions help track outcomes and evaluate safety. Programs like the US CMS’s Quality Payment Program encourage registry use, fostering structured data collection, better clinical insights, and broader adoption across healthcare systems worldwide.
Restraint: Data privacy and security concerns
Data privacy and security continue to pose significant challenges, as compliance with HIPAA, GDPR, and other regulations raises costs and increases complexity for vendors and providers. The threat of breaches and misuse discourages smaller players from adopting registries. Issues related to patient consent, cross-border data transfers, and secondary data use often delay implementation or restrict scope, ultimately limiting registry growth and market expansion.
Opportunity: Integration with AI and analytics tools
AI integration in patient registries offers opportunities to analyze long-term data, identify disease patterns, and customize treatments. Improved interoperability with EHRs and mobile apps allows seamless real-time data collection. Increasing adoption across Asia Pacific, the Middle East, and Latin America, supported by national digital health initiatives, further drives demand. Decentralized trials and remote monitoring broaden registry applications, strengthening long-term market growth.
Challenge: Inconsistent data quality and completeness
Registry effectiveness is limited by poor data quality, where missing, inaccurate, or non-standardized entries weaken reliability. Manual input errors, lack of interoperability, and inconsistent documentation create gaps. Retrospective or self-reported data introduce recall bias. Without automated validation tools, insights remain unreliable. Solving these issues requires standardized protocols, EHR integration, and AI-driven validation to ensure data accuracy, consistency, and trustworthiness.
patient registry software market: COMMERCIAL USE CASES ACROSS INDUSTRIES
| COMPANY | USE CASE DESCRIPTION | BENEFITS |
|---|---|---|
 |
AI-enabled registries integrating EHR data, claims, and real-world evidence for oncology and chronic disease tracking Improved clinical decision support, early diagnosis, predictive insights | Improved clinical decision support, early diagnosis, predictive insights |
 |
Patient registries for clinical trials and post-marketing surveillance across pharma and biotech Accelerated drug development, enhanced recruitment/retention, regulatory compliance | Accelerated drug development, enhanced recruitment/retention, regulatory compliance |
 |
Cloud-based disease registries for cardiovascular and diabetes care management | Better population health outcomes, reduced hospital readmissions, cost efficiency |
 |
Rare disease and specialty registries integrating payer and provider datasets | Optimized care pathways, improved reimbursement accuracy, value-based care alignment |
 |
Cloud-based patient registry solutions that integrate EHR, lab, and patient-reported data to support longitudinal tracking, analytics, and compliance | Improves clinical outcomes, enhances research and RWE, ensures regulatory compliance, boosts efficiency, and scales for national/global registries |
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET ECOSYSTEM
The patient registry software market ecosystem includes providers such as IBM, IQVIA, Veradigm, and Optum, offering interoperable, cloud-based platforms for disease tracking and research. Technology partners improve AI, analytics, and security capabilities. End users such as pharmaceutical companies, payers, providers, nonprofits, and governments use registries for evidence generation and care coordination. Regulators such as the FDA and EMA enforce standards, while funding agencies promote adoption, collectively advancing data-driven healthcare innovation. Collaboration across the entire value chain is essential for innovation and market growth.
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET SEGMENTS
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
Patient Registry Software Market, By Registry Type
The disease registry segment dominates the patient registry software market due to the growing burden of chronic and rare diseases. According to Rare Diseases International (2025), over 300 million people worldwide live with a rare disease, representing 3.5%–5.9% of the global population. This rising prevalence is driving demand for registries to enable early diagnosis, strengthen clinical research, and support targeted therapy development. Furthermore, integration with EHRs and wearable devices has enhanced their role in population health management by offering structured, real-world data.
Patient Registry Software Market, By Use Case
In 2024, the medical research and clinical studies segment led the patient registry software market, driven by increasing demand for real-world evidence (RWE) to support drug development and regulatory processes. Research institutions and life science companies use patient registries to collect longitudinal data for clinical trials and population studies. The focus on precision medicine and government funding to improve clinical research infrastructure further accelerates the adoption of registry software in this sector.
Patient Registry Software Market, By Deployment Model
In 2024, the cloud-based model segment led the patient registry software market, driven by the push for digital transformation, focusing on agility and cost savings. Cloud registries offer real-time data access, scalability, and integration with digital health tools and EHRs, making them attractive to hospitals and public health organizations for collaboration and remote data collection. Companies like Dacima Software and Arbor Metrix are experiencing growing demand for their cloud-native platforms, which provide automated analytics and secure, compliant hosting. Furthermore, the increase in SaaS adoption and government incentives for cloud infrastructure support the growth of this segment.
REGION
North America is expected to dominate the global patient experience technology market in 2025
The North America patient registry software market is projected to lead the global market in 2025, bolstered by advanced healthcare infrastructure, robust IT systems, and favorable regulations. Increasing adoption of EHRs, interoperability efforts, and remote patient monitoring for chronic disease management serve as key growth drivers. The presence of global giants such as Oracle, IBM, IQVIA, Optum, and Health Catalyst strengthens the US market. Innovative initiatives further demonstrate momentum—such as the National Pancreas Foundation’s registry launch and Health Catalyst’s CMS-approved Able Health Registry. These developments position patient registries as vital tools for improving health outcomes, advancing precision medicine, and supporting evidence-based healthcare decisions.
patient registry software market: COMPANY EVALUATION MATRIX
In the patient registry software market matrix, IBM (Star) leads with a strong market share and extensive product footprint, driven by its advanced interoperability solutions, AI-enabled analytics, and deep integration capabilities across healthcare ecosystems. Conduent Incorporated (Emerging Leader) is gaining visibility with its patient data management and workflow automation solutions, strengthening its position through innovation and niche product offerings. While IBM dominates through scale, global presence, and diversified registry solutions spanning clinical trials, disease registries, and population health management, Conduent Incorporated shows significant potential to move toward the Leaders’ Quadrant as demand for cloud-based, cost-efficient, and patient-centric registry platforms continues to rise.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
KEY MARKET PLAYERS
- IBM
- IQVIA
- Health Catalyst Inc.
- Oracle
- UnitedHealth Group
- Conduent Inc.
- Elekta
- Dassault Systèmes
- EvidentIQ (Dacima Software Inc.)
- MRO (Figmd, Inc.)
- ImageTrend, Inc.
- Global Vision Technologies, Inc.
- Syneos Health
- Veradigm LLC
- ESO
- Ordinal Data, Inc.
- Lumedx Corporation
- NEC Corporation (NEC Software Solutions UK Limited)
- Cedaron Medical
MARKET SCOPE
| REPORT METRIC | DETAILS |
|---|---|
| Market Size in 2024 (Value) | USD 2.07 Billion |
| Market Forecast in 2030 (value) | USD 3.61 Billion |
| Growth Rate | CAGR of 9.9% from 2025–2030 |
| Years Considered | 2023–2030 |
| Base Year | 2024 |
| Forecast Period | 2025-2030 |
| Units Considered | Value (USD Million/Billion) |
| Report Coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends. |
| Segments Covered |
|
| Regions Covered | North America, Asia Pacific, Europe, Latin America, Middle East & Africa |
WHAT IS IN IT FOR YOU: patient registry software market REPORT CONTENT GUIDE
DELIVERED CUSTOMIZATIONS
We have successfully delivered the following deep-dive customizations:
| CLIENT REQUEST | CUSTOMIZATION DELIVERED | VALUE ADDS |
|---|---|---|
| Market Sizing & Segmentation (Module 1) | Estimated current market size of patient registry software for non-profits, medical specialty societies & patient organizations (US and global). Forecast of market growth for the next 5–6 years. Segmentation by registry type (direct-to-patient vs aggregated), adoption patterns, end users, and regions. Geographic breakdown by US and global, functionalities, products, and end users. Identification of new & emerging technologies and use cases. Analysis of key growth drivers (e.g., outcome-based healthcare, disease-specific data, research/clinical trials). Assessment of major challenges & barriers (data privacy, HIPAA compliance, budgets for non-profits & societies). | Clear visibility on market potential and opportunity sizing. Supports strategic resource allocation across regions and end-user groups. Enables prioritization of high-growth segments and technologies. Risk mitigation through early identification of regulatory and budgetary barriers. |
| Competition Landscape & Benchmarking (Module 2) | Identification of the top 10–15 global competitors with profiles on strengths, market share, and positioning. Evaluation of leadership strategies (unique products, superior tech, partnerships) Benchmarking of product types (direct-to-patient vs aggregated) and value propositions Analysis of how strategies contribute to market position. Mapping of differentiators that provide a competitive edge Tracking emerging trends & use cases for medical societies and patient orgs. Profiling new entrants and disruptive players | Insight into competitive intensity and market share dynamics. Guidance on countering or leveraging leading players’ strategies. Identification of whitespace opportunities & differentiation levels. Early awareness of disruptive innovations and market newcomers |
RECENT DEVELOPMENTS
- February 2025 : The Oklahoma State Department of Health partnered with Conduent to implement the AI-enabled Maven Disease Surveillance and Outbreak Management System. This cloud-based platform enhances real-time monitoring, tracking, and reporting of public health threats, thereby improving outbreak response and safeguarding Oklahoma’s 4 million residents
- June 2024 : IBM launched InfoSphere Master Data Management 14.0, which introduced improved data governance, seamless integration, advanced compliance features, and robust data management capabilities. These enhancements aim to accelerate digital transformation across enterprises.
- February 2024 : Health Catalyst's Able Health Registry received approval from the Centers for Medicare & Medicaid Services (CMS) as a Qualified Registry for the Quality Payment Program (QPP) for the 2024 performance year. This approval enables the registry to calculate and report QPP program measures, ultimately improving care quality and reducing the administrative burden on clinicians
Table of Contents
Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.
TITLE
PAGE NO
1
INTRODUCTION
34
2
RESEARCH METHODOLOGY
40
3
EXECUTIVE SUMMARY
56
4
PREMIUM INSIGHTS
62
5
MARKET OVERVIEW
Digital health tech and cloud solutions drive patient-centered care and registry expansion.
66
5.1
INTRODUCTION
5.2
MARKET DYNAMICS
5.2.1
MARKET DYNAMICS
5.2.1.1
RISING BURDEN OF CHRONIC AND RARE DISEASES
5.2.1.2
SHIFT TOWARD VALUE-BASED AND PATIENT-CENTERED CARE
5.2.1.3
EXPANSION OF REAL-WORLD EVIDENCE (RWE) AND POST-MARKETING SURVEILLANCE NEEDS
5.2.1.4
INCREASING USE OF DIGITAL HEALTH TECHNOLOGIES AND INTEROPERABLE EHRS
5.2.1.5
GOVERNMENT AND REGULATORY INCENTIVES FOR REGISTRY IMPLEMENTATION
5.2.2
MARKET RESTRAINTS
5.2.2.1
SHORTAGE OF TRAINED AND SKILLED RESOURCES
5.2.2.2
HIGH IMPLEMENTATION AND MAINTENANCE COSTS
5.2.3
MARKET OPPORTUNITIES
5.2.3.1
EXPANSION OF POPULATION HEALTH MANAGEMENT AND OUTCOMES TRACKING
5.2.3.2
RISING DEMAND FOR PREGNANCY AND CONGENITAL ANOMALY REGISTRIES FOR MATERNAL-FETAL SAFETY MONITORING
5.2.3.3
GROWING PREFERENCE FOR SUBSCRIPTION-BASED DEPLOYMENT MODELS
5.2.4
MARKET CHALLENGES
5.2.4.1
PRIVACY- AND DATA SECURITY-RELATED CONCERNS
5.2.4.2
RELUCTANCE TO ADOPT ADVANCED PATIENT REGISTRY SOLUTIONS
5.2.4.3
LIMITED AWARENESS AMONG HEALTHCARE STAKEHOLDERS
5.3
TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.4
INDUSTRY TRENDS
5.4.1
STRENGTHENED FUNDING FOR PATIENT-CENTERED RESEARCH AND RARE DISEASE REGISTRIES
5.4.2
RISE IN AUTOMATED DATA ENTRY AND REGISTRY INTELLIGENCE
5.4.3
CLOUD-BASED REGISTRIES AND DECENTRALIZED ACCESS
5.5
ECOSYSTEM ANALYSIS
5.6
VALUE CHAIN ANALYSIS
5.7
TECHNOLOGY ANALYSIS
5.7.1
KEY TECHNOLOGIES
5.7.1.1
ELECTRONIC DATA CAPTURE (EDC) SYSTEMS
5.7.1.2
CLOUD COMPUTING & SAAS ARCHITECTURE
5.7.1.3
DATA PRIVACY & SECURITY TECHNOLOGIES
5.7.2
COMPLEMENTARY TECHNOLOGIES
5.7.2.1
ELECTRONIC HEALTH RECORD (EHR) SYSTEMS
5.7.2.2
CLINICAL TRIAL MANAGEMENT SYSTEMS (CTMS)
5.7.3
ADJACENT TECHNOLOGIES
5.7.3.1
DIGITAL THERAPEUTICS (DTX) PLATFORMS
5.7.3.2
WEARABLE DEVICES & REMOTE MONITORING TOOLS
5.7.3.3
BLOCKCHAIN FOR HEALTH DATA MANAGEMENT
5.8
REGULATORY ANALYSIS
5.8.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.8.2
REGULATORY LANDSCAPE
5.8.2.1
NORTH AMERICA
5.8.2.2
EUROPE
5.8.2.3
ASIA PACIFIC
5.8.2.4
MIDDLE EAST & AFRICA
5.8.2.5
LATIN AMERICA
5.9
PRICING ANALYSIS
5.9.1
AVERAGE COST OF PATIENT REGISTRY SOFTWARE, BY END USER (2024)
5.9.2
INDICATIVE PRICE OF PATIENT REGISTRY SOFTWARE, BY REGION (2024)
5.10
PORTER’S FIVE FORCES ANALYSIS
5.10.1
INTENSITY OF COMPETITIVE RIVALRY
5.10.2
BARGAINING POWER OF BUYERS
5.10.3
THREAT OF SUBSTITUTES
5.10.4
THREAT OF NEW ENTRANTS
5.10.5
BARGAINING POWER OF SUPPLIERS
5.11
PATENT ANALYSIS
5.11.1
PATENT PUBLICATION TRENDS FOR PATIENT REGISTRY SOFTWARE MARKET
5.11.2
JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR PATIENT REGISTRY SOFTWARE
5.11.3
MAJOR PATENTS IN PATIENT REGISTRY SOFTWARE MARKET
5.12
KEY STAKEHOLDERS & BUYING CRITERIA
5.12.1
KEY STAKEHOLDERS IN BUYING PROCESS
5.12.2
KEY BUYING CRITERIA
5.13
END-USER ANALYSIS
5.13.1
UNMET NEEDS
5.13.2
END-USER EXPECTATIONS
5.14
KEY CONFERENCES & EVENTS, 2025–2026
5.15
CASE STUDY ANALYSIS
5.16
INVESTMENT & FUNDING SCENARIO
5.17
BUSINESS MODEL ANALYSIS
5.18
IMPACT OF AI/GEN AI ON PATIENT REGISTRY SOFTWARE MARKET
5.18.1
TOP USE CASES & MARKET POTENTIAL
5.18.2
KEY USE CASES
5.18.3
CASE STUDIES OF AI/GENERATIVE AI IMPLEMENTATION
5.18.3.1
CASE STUDY: AI-POWERED DATA SUMMARIZATION IMPROVES REGISTRY UTILIZATION EFFICIENCY
5.18.4
ELECTRONIC HEALTH RECORD (EHR) MARKET
5.18.5
REAL WORLD EVIDENCE (RWE) MARKET
5.18.6
USER READINESS AND IMPACT ASSESSMENT
5.18.6.1
USER READINESS
5.18.6.2
IMPACT ASSESSMENT
5.19
IMPACT OF 2025 US TARIFFS ON PATIENT REGISTRY SOFTWARE MARKET
5.19.1
INTRODUCTION
5.19.2
KEY TARIFF RATES
5.19.3
PRICE IMPACT ANALYSIS
5.19.3.1
CLOUD HOSTING INFRASTRUCTURE
5.19.3.2
AI & ANALYTICS MODULES
5.19.3.3
OFFSHORE DEVELOPMENT & SUPPORT SERVICES
5.19.4
IMPACT ON COUNTRY/REGION
5.19.4.1
US
5.19.4.2
EUROPE
5.19.4.3
ASIA PACIFIC
5.19.5
IMPACT ON END-USE INDUSTRIES
5.19.5.1
FOR-PROFIT REGISTRIES
5.19.5.2
NONPROFIT REGISTRIES
5.19.5.3
GOVERNMENT & THIRD-PARTY ADMINISTRATORS
5.19.5.4
OTHERS
6
PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 17 Data Tables
118
6.1
INTRODUCTION
6.2
DISEASE REGISTRIES
6.2.1
DIABETES REGISTRIES
6.2.1.1
NEED TO MONITOR DISEASE PREVALENCE, TREATMENT ADHERENCE, AND LONG-TERM COMPLICATIONS TO BOOST ADOPTION
6.2.2
CARDIOVASCULAR REGISTRIES
6.2.2.1
ABILITY OF CARDIOVASCULAR REGISTRIES TO ENABLE HEALTHCARE SYSTEMS TO BENCHMARK CARE QUALITY AND IDENTIFY TREATMENT GAPS TO BOOST GROWTH
6.2.3
CANCER REGISTRIES
6.2.3.1
CRITICAL TOOLS FOR UNDERSTANDING CANCER EPIDEMIOLOGY AND EVALUATING SCREENING PROGRAMS TO DRIVE MARKET
6.2.4
RARE DISEASE REGISTRIES
6.2.4.1
ESSENTIAL TOOLS FOR ADVANCING KNOWLEDGE ABOUT RARE DISEASES TO SUPPORT MARKET GROWTH
6.2.5
ASTHMA REGISTRIES
6.2.5.1
IMPROVING ASTHMA MANAGEMENT AND REDUCING EXACERBATIONS TO FUEL GROWTH
6.2.6
CHRONIC KIDNEY REGISTRIES
6.2.6.1
ABILITY OF REGISTRIES TO COLLECT DETAILED DATA ON DISEASE PROGRESSION, LAB RESULTS, AND TREATMENT ADHERENCE TO BOOST ADOPTION
6.2.7
ORTHOPEDIC REGISTRIES
6.2.7.1
ABILITY TO MONITOR IMPLANT PERFORMANCE, SURGICAL OUTCOMES, AND COMPLICATION RATES TO DRIVE GROWTH
6.2.8
IMMUNIZATION REGISTRIES
6.2.8.1
STRENGTHENING VACCINE COVERAGE AND SAFETY MONITORING TO PROPEL MARKET
6.2.9
BIRTH DEFECT REGISTRIES
6.2.9.1
NEED TO TRACK AND PREVENT CONGENITAL ANOMALIES THROUGH BIRTH DEFECT REGISTRIES TO PROPEL MARKET GROWTH
6.2.10
OTHER DISEASE REGISTRIES
6.3
PRODUCT REGISTRIES
6.3.1
MEDICAL DEVICE REGISTRIES
6.3.1.1
ABILITY OF THESE REGISTRIES TO ENHANCE SAFETY, PERFORMANCE MONITORING, AND REGULATORY COMPLIANCE TO BOOST GROWTH
6.3.2
DRUG REGISTRIES
6.3.2.1
ABILITY TO SUPPORT LONG-TERM SAFETY, REAL-WORLD EVIDENCE, AND OPTIMAL THERAPY USE TO PROPEL GROWTH
7
PATIENT REGISTRY SOFTWARE MARKET, BY PRODUCT
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 3 Data Tables
132
7.1
INTRODUCTION
7.2
DIRECT-TO-PATIENT (PATIENT-RECORDED) REGISTRIES
7.2.1
INCREASING PATIENT ENGAGEMENT AND DEMAND FOR SELF-REPORTED DATA TO BOOST MARKET GROWTH
7.3
SITE-BASED/CLINICAL DATA (PROVIDER-RECORDED) REGISTRIES
7.3.1
GROWING NEED FOR ACCURATE, CLINICIAN-VERIFIED DATA AND SEAMLESS EHR INTEGRATION TO SUPPORT GROWTH
8
PATIENT REGISTRY SOFTWARE MARKET, BY USE CASE
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 10 Data Tables
136
8.1
INTRODUCTION
8.2
MEDICAL RESEARCH & CLINICAL STUDIES
8.2.1
GROWING NEED TO LEVERAGE REGISTRIES TO ENHANCE REAL-WORLD EVIDENCE AND CLINICAL TRIAL EFFICIENCY TO FUEL GROWTH
8.3
QUALITY IMPROVEMENT
8.3.1
ADVANTAGES SUCH AS EVIDENCE-BASED PRACTICE AND PERFORMANCE BENCHMARKING TO DRIVE SEGMENTAL GROWTH
8.4
PATIENT CARE MANAGEMENT
8.4.1
ABILITY TO EMPOWER PROACTIVE CHRONIC DISEASE MANAGEMENT THROUGH CENTRALIZED REGISTRIES TO SUPPORT GROWTH
8.5
POPULATION HEALTH
8.5.1
EXPANDING ROLE OF PATIENT MANAGEMENT SYSTEMS IN DRIVING DIGITAL TRANSFORMATION TO CONTRIBUTE TO GROWTH
8.6
POINT-OF-CARE SUPPORT
8.6.1
NEED FOR PERSONALIZED TREATMENT PLANS AND SHARED DECISION-MAKING TO DRIVE EFFICIENCY AND QUALITY IN HEALTHCARE
8.7
PUBLIC HEALTH SURVEILLANCE
8.7.1
ABILITY OF REGISTRIES TO ENHANCE PREPAREDNESS AND RESPONSE CAPABILITIES TO DRIVE SEGMENTAL GROWTH
8.8
PATIENT SELF-CARE
8.8.1
GROWING EMPHASIS ON PATIENT EMPOWERMENT AND SELF-MANAGEMENT TO PROPEL GROWTH
8.9
PATIENT ENGAGEMENT
8.9.1
ADVANTAGES SUCH AS BETTER DATA ACCURACY AND MORE MEANINGFUL OUTCOMES TO BOOST GROWTH
8.10
OTHER USE CASES
9
PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 3 Data Tables
147
9.1
INTRODUCTION
9.2
ON-PREMISE MODELS
9.2.1
GROWING DEMAND FOR SECURITY, CONTROL, AND COMPLIANCE TO DRIVE MARKET GROWTH
9.3
CLOUD-BASED MODELS
9.3.1
SCALABILITY, INTEROPERABILITY, AND COST-EFFECTIVENESS OF CLOUD-BASED MODELS TO DRIVE GROWTH
10
PATIENT REGISTRY SOFTWARE MARKET, BY END USER
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 16 Data Tables
151
10.1
INTRODUCTION
10.2
FOR-PROFIT REGISTRIES
10.2.1
PHARMACEUTICAL, BIOTECHNOLOGY, AND MEDTECH COMPANIES
10.2.1.1
NEED FOR ROBUST EVIDENCE GENERATION, ENHANCED PATIENT SAFETY, AND COMPETITIVE DIFFERENTIATION TO DRIVE ADOPTION
10.2.2
HEALTHCARE PAYERS
10.2.2.1
NEED TO IMPROVE POPULATION HEALTH MANAGEMENT, CONTROL COSTS, AND ASSESS TREATMENT VALUE TO DRIVE DEMAND
10.2.3
HEALTHCARE PROVIDERS
10.2.3.1
HOSPITALS
10.2.3.2
CLINICS & OUTPATIENT SETTINGS
10.2.3.3
OTHER HEALTHCARE PROVIDERS
10.3
NONPROFIT REGISTRIES
10.3.1
MEDICAL SPECIALTY SOCIETIES
10.3.1.1
ADVANTAGES SUCH AS DEFINED BEST PRACTICES AND IMPROVED CARE DELIVERY TO PROPEL GROWTH
10.3.2
PATIENT ORGANIZATIONS
10.3.2.1
IMPORTANCE OF FACILITATING CLINICAL TRIAL RECRUITMENT AND FOSTERING COLLABORATION WITH RESEARCHERS TO SUPPORT GROWTH
10.4
GOVERNMENT & THIRD-PARTY ADMINISTRATORS
10.4.1
ABILITY OF GOVERNMENT-RUN REGISTRIES TO EVALUATE SUCCESS OF HEALTHCARE INITIATIVES TO FUEL MARKET
10.5
OTHER END USERS
11
PATIENT REGISTRY SOFTWARE MARKET, BY REGION
Comprehensive coverage of 8 Regions with country-level deep-dive of 12 Countries | 226 Data Tables.
165
11.1
INTRODUCTION
11.2
NORTH AMERICA
11.2.1
MACROECONOMIC OUTLOOK FOR NORTH AMERICA
11.2.2
US
11.2.2.1
US TO DOMINATE GLOBAL MARKET FOR PATIENT REGISTRY SOFTWARE
11.2.3
CANADA
11.2.3.1
GOVERNMENT INVESTMENT, COLLABORATIVE INITIATIVES, AND STRONG PUSH TO STANDARDIZE RARE DISEASE REGISTRIES TO DRIVE GROWTH
11.3
EUROPE
11.3.1
MACROECONOMIC OUTLOOK FOR EUROPE
11.3.2
UK
11.3.2.1
GROWING INCIDENCE OF CANCER TO DRIVE MARKET GROWTH
11.3.3
GERMANY
11.3.3.1
NATIONAL ROLLOUT OF E-PATIENT FILES AND RARE DISEASE REGISTRIES TO STRENGTHEN PATIENT CARE AND RESEARCH
11.3.4
FRANCE
11.3.4.1
GROWING PATIENT REGISTRY ADOPTION WITH NATIONAL DATA PLATFORMS AND RARE DISEASE INITIATIVES TO SUPPORT MARKET GROWTH
11.3.5
ITALY
11.3.5.1
GROWING NUMBER OF NATIONAL NETWORKS AND DISEASE-SPECIFIC REGISTRIES TO DRIVE GROWTH
11.3.6
SPAIN
11.3.6.1
GROWING NEED TO ADDRESS RISING CHRONIC AND CARDIOVASCULAR DISEASE PREVALENCE TO DRIVE ADOPTION
11.3.7
REST OF EUROPE
11.4
ASIA PACIFIC
11.4.1
MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
11.4.2
JAPAN
11.4.2.1
JAPAN’S AGING POPULATION AND ADVANCED DIGITAL STRATEGIES TO DRIVE GROWTH IN PATIENT REGISTRY SOFTWARE MARKET
11.4.3
CHINA
11.4.3.1
ROBUST NATIONAL REGISTRIES AND EXPANDING PHARMACEUTICAL APPROVALS TO DRIVE PATIENT REGISTRY SOFTWARE MARKET
11.4.4
INDIA
11.4.4.1
DIGITAL HEALTH ADVANCES TO BOOST INDIA’S PATIENT REGISTRY SOFTWARE MARKET
11.4.5
REST OF ASIA PACIFIC
11.5
LATIN AMERICA
11.5.1
MACROECONOMIC OUTLOOK FOR LATIN AMERICA
11.5.2
BRAZIL
11.5.2.1
BRAZIL TO DOMINATE PATIENT REGISTRY SOFTWARE MARKET IN LATIN AMERICA
11.5.3
MEXICO
11.5.3.1
INCREASE IN FOCUS OF DIGITAL HEALTH TO BOOST MARKET GROWTH
11.5.4
REST OF LATIN AMERICA
11.6
MIDDLE EAST & AFRICA
11.6.1
MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
11.6.2
GCC COUNTRIES
11.6.2.1
RISING HEALTHCARE INVESTMENTS TO FUEL UPTAKE
11.6.3
REST OF MIDDLE EAST & AFRICA
12
COMPETITIVE LANDSCAPE
Discover key player strategies and market dynamics shaping patient registry software's competitive edge.
281
12.1
OVERVIEW
12.2
KEY PLAYER STRATEGIES/RIGHT TO WIN
12.2.1
OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN PATIENT REGISTRY SOFTWARE MARKET
12.3
REVENUE ANALYSIS, 2020–2024
12.4
MARKET SHARE ANALYSIS, 2024
12.5
COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
12.5.1
STARS
12.5.2
EMERGING LEADERS
12.5.3
PERVASIVE PLAYERS
12.5.4
PARTICIPANTS
12.5.5
COMPANY FOOTPRINT: KEY PLAYERS, 2024
12.5.5.1
COMPANY FOOTPRINT
12.5.5.2
REGION FOOTPRINT
12.5.5.3
PRODUCT FOOTPRINT
12.5.5.4
USE CASE FOOTPRINT
12.5.5.5
REGISTRY TYPE FOOTPRINT
12.5.5.6
DEPLOYMENT FOOTPRINT
12.5.5.7
END-USER FOOTPRINT
12.6
COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
12.6.1
PROGRESSIVE COMPANIES
12.6.2
RESPONSIVE COMPANIES
12.6.3
DYNAMIC COMPANIES
12.6.4
STARTING BLOCKS
12.6.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
12.6.5.1
DETAILED LIST OF KEY STARTUPS/SMES
12.6.5.2
COMPETITIVE BENCHMARKING OF STARTUPS/SMES
12.7
COMPANY VALUATION & FINANCIAL METRICS
12.7.1
FINANCIAL METRICS
12.7.2
COMPANY VALUATION
12.8
BRAND/SOFTWARE COMPARISON
12.9
COMPETITIVE SCENARIO
12.9.1
PRODUCT LAUNCHES, APPROVALS, UPGRADES, AND ENHANCEMENTS
12.9.2
DEALS
12.9.3
OTHER DEVELOPMENTS
13
COMPANY PROFILES
In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)
304
13.1
KEY PLAYERS
13.1.1
IBM
13.1.1.1
BUSINESS OVERVIEW
13.1.1.2
PRODUCTS OFFERED
13.1.1.3
RECENT DEVELOPMENTS
13.1.1.4
MNM VIEW
13.1.2
IQVIA HOLDINGS INC.
13.1.3
HEALTH CATALYST, INC.
13.1.4
ORACLE
13.1.5
UNITEDHEALTH GROUP
13.1.6
CONDUENT INCORPORATED
13.1.7
ELEKTA
13.1.8
NEC CORPORATION (NEC SOFTWARE SOLUTIONS UK LIMITED)
13.1.9
DASSAULT SYSTÈMES (MEDIDATA)
13.1.10
EVIDENTIQ (DACIMA SOFTWARE INC.)
13.1.11
MRO (FIGMD, INC.)
13.1.12
IMAGETREND
13.1.13
GLOBAL VISION TECHNOLOGIES, INC.
13.1.14
SYNEOS HEALTH
13.1.15
VERADIGM LLC
13.1.16
ESO
13.1.17
ORDINAL DATA INC.
13.1.18
CEDARON MEDICAL
13.1.19
FIVOS HEALTH
13.1.20
ACROSS HEALTHCARE
13.2
OTHER PLAYERS
13.2.1
VERANA HEALTH
13.2.2
PULSE INFOFRAME INC.
13.2.3
AMPLITUDE CLINICAL OUTCOMES
13.2.4
NPHASE, INC. (REDCAP CLOUD)
13.2.5
OM1
14
APPENDIX
372
14.1
DISCUSSION GUIDE
14.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
14.3
CUSTOMIZATION OPTIONS
14.4
RELATED REPORTS
14.5
AUTHOR DETAILS
LIST OF TABLES
TABLE 1
EXCHANGE RATES UTILIZED FOR CONVERSION TO USD
TABLE 2
FACTOR ANALYSIS
TABLE 3
RISK ASSESSMENT: PATIENT REGISTRY SOFTWARE MARKET
TABLE 4
PATIENT REGISTRY SOFTWARE MARKET: IMPACT ANALYSIS
TABLE 5
HEALTHCARE DATA BREACHES IN US
TABLE 6
PATIENT REGISTRY SOFTWARE MARKET: ROLE IN ECOSYSTEM
TABLE 7
NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 8
EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 9
ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 10
LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 11
MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 12
REGULATORY SCENARIO OF NORTH AMERICA
TABLE 13
REGULATORY SCENARIO OF EUROPE
TABLE 14
REGULATORY SCENARIO OF ASIA PACIFIC
TABLE 15
REGULATORY SCENARIO OF MIDDLE EAST & AFRICA
TABLE 16
REGULATORY SCENARIO OF LATIN AMERICA
TABLE 17
AVERAGE COST OF PATIENT REGISTRY SOFTWARE, BY END USER (ORDINAL HEALTH INC.) (2024)
TABLE 18
INDICATIVE PRICE RANGE OF PATIENT REGISTRY SOFTWARE, BY REGION (2024)
TABLE 19
PATIENT REGISTRY SOFTWARE MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 20
JURISDICTION ANALYSIS OF TOP APPLICANT COUNTRIES FOR PATIENT REGISTRY SOFTWARE
TABLE 21
PATIENT REGISTRY SOFTWARE MARKET: LIST OF PATENTS/PATENT APPLICATIONS
TABLE 22
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF TOP THREE END USERS (%)
TABLE 23
KEY BUYING CRITERIA FOR TOP THREE END USERS
TABLE 24
UNMET NEEDS IN PATIENT REGISTRY SOFTWARE MARKET
TABLE 25
END-USER EXPECTATIONS IN PATIENT REGISTRY SOFTWARE MARKET
TABLE 26
PATIENT REGISTRY SOFTWARE MARKET: KEY CONFERENCES & EVENTS, 2025–2026
TABLE 27
CASE STUDY 1: CANCER REGISTRY IMPLEMENTATION WITH DACIMA CLINICAL SUITE
TABLE 28
CASE STUDY 2: ENHANCING REAL-WORLD EVIDENCE WITH CASTOR RWE
TABLE 29
CASE STUDY 3: DEVICE DATA INTEGRATION USING MEDIREPORT 360
TABLE 30
US-ADJUSTED RECIPROCAL TARIFF RATES
TABLE 31
PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2023–2030 (USD MILLION)
TABLE 32
PATIENT REGISTRY SOFTWARE MARKET FOR DISEASE REGISTRIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 33
PATIENT REGISTRY SOFTWARE MARKET FOR DISEASE REGISTRIES, BY REGION, 2023–2030 (USD MILLION)
TABLE 34
PATIENT REGISTRY SOFTWARE MARKET FOR DIABETES REGISTRIES, BY REGION, 2023–2030 (USD MILLION)
TABLE 35
PATIENT REGISTRY SOFTWARE MARKET FOR CARDIOVASCULAR REGISTRIES, BY REGION, 2023–2030 (USD MILLION)
TABLE 36
PATIENT REGISTRY SOFTWARE MARKET FOR CANCER REGISTRIES, BY REGION, 2023–2030 (USD MILLION)
TABLE 37
PATIENT REGISTRY SOFTWARE MARKET FOR RARE DISEASE REGISTRIES, BY REGION, 2023–2030 (USD MILLION)
TABLE 38
PATIENT REGISTRY SOFTWARE MARKET FOR ASTHMA REGISTRIES, BY REGION, 2023–2030 (USD MILLION)
TABLE 39
PATIENT REGISTRY SOFTWARE MARKET FOR CHRONIC KIDNEY REGISTRIES, BY REGION, 2023–2030 (USD MILLION)
TABLE 40
PATIENT REGISTRY SOFTWARE MARKET FOR ORTHOPEDIC REGISTRIES, BY REGION, 2023–2030 (USD MILLION)
TABLE 41
PATIENT REGISTRY SOFTWARE MARKET FOR IMMUNIZATION REGISTRIES, BY REGION, 2023–2030 (USD MILLION)
TABLE 42
PATIENT REGISTRY SOFTWARE MARKET FOR BIRTH DEFECT REGISTRIES, BY REGION, 2023–2030 (USD MILLION)
TABLE 43
PATIENT REGISTRY SOFTWARE MARKET FOR OTHER DISEASE REGISTRIES, BY REGION, 2023–2030 (USD MILLION)
TABLE 44
PATIENT REGISTRY SOFTWARE MARKET FOR PRODUCT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 45
PATIENT REGISTRY SOFTWARE MARKET FOR PRODUCT REGISTRIES, BY REGION, 2023–2030 (USD MILLION)
TABLE 46
PATIENT REGISTRY SOFTWARE MARKET FOR MEDICAL DEVICE REGISTRIES, BY REGION, 2023–2030 (USD MILLION)
TABLE 47
PATIENT REGISTRY SOFTWARE MARKET FOR DRUG REGISTRIES, BY REGION, 2023–2030 (USD MILLION)
TABLE 48
PATIENT REGISTRY SOFTWARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 49
PATIENT REGISTRY SOFTWARE MARKET FOR DIRECT-TO-PATIENT (PATIENT-RECORDED) REGISTRIES, BY REGION, 2023–2030 (USD MILLION)
TABLE 50
PATIENT REGISTRY SOFTWARE MARKET FOR SITE-BASED/CLINICAL DATA (PROVIDER-RECORDED) REGISTRIES, BY REGION, 2023–2030 (USD MILLION)
TABLE 51
PATIENT REGISTRY SOFTWARE MARKET, BY USE CASE, 2023–2030 (USD MILLION)
TABLE 52
PATIENT REGISTRY SOFTWARE MARKET FOR MEDICAL RESEARCH & CLINICAL STUDIES, BY REGION, 2023–2030 (USD MILLION)
TABLE 53
PATIENT REGISTRY SOFTWARE MARKET FOR QUALITY IMPROVEMENT, BY REGION, 2023–2030 (USD MILLION)
TABLE 54
PATIENT REGISTRY SOFTWARE MARKET FOR PATIENT CARE MANAGEMENT, BY REGION, 2023–2030 (USD MILLION)
TABLE 55
PATIENT REGISTRY SOFTWARE MARKET FOR POPULATION HEALTH, BY REGION, 2023–2030 (USD MILLION)
TABLE 56
PATIENT REGISTRY SOFTWARE MARKET FOR POINT-OF-CARE SUPPORT, BY REGION, 2023–2030 (USD MILLION)
TABLE 57
PATIENT REGISTRY SOFTWARE MARKET FOR PUBLIC HEALTH SURVEILLANCE, BY REGION, 2023–2030 (USD MILLION)
TABLE 58
PATIENT REGISTRY SOFTWARE MARKET FOR PATIENT SELF-CARE, BY REGION, 2023–2030 (USD MILLION)
TABLE 59
PATIENT REGISTRY SOFTWARE MARKET FOR PATIENT ENGAGEMENT, BY REGION, 2023–2030 (USD MILLION)
TABLE 60
PATIENT REGISTRY SOFTWARE MARKET FOR OTHER USE CASES, BY REGION, 2023–2030 (USD MILLION)
TABLE 61
PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT, 2023–2030 (USD MILLION)
TABLE 62
PATIENT REGISTRY SOFTWARE MARKET FOR ON-PREMISE MODELS, BY REGION, 2023–2030 (USD MILLION)
TABLE 63
PATIENT REGISTRY SOFTWARE MARKET FOR CLOUD-BASED MODELS, BY REGION, 2023–2030 (USD MILLION)
TABLE 64
PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 65
PATIENT REGISTRY SOFTWARE MARKET FOR FOR-PROFIT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 66
PATIENT REGISTRY SOFTWARE MARKET FOR FOR-PROFIT REGISTRIES, BY REGION, 2023–2030 (USD MILLION)
TABLE 67
PATIENT REGISTRY SOFTWARE MARKET FOR PHARMACEUTICAL, BIOTECHNOLOGY, AND MEDTECH COMPANIES, BY REGION, 2023–2030 (USD MILLION)
TABLE 68
PATIENT REGISTRY SOFTWARE MARKET FOR HEALTHCARE PAYERS, BY REGION, 2023–2030 (USD MILLION)
TABLE 69
PATIENT REGISTRY SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 70
PATIENT REGISTRY SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY REGION, 2023–2030 (USD MILLION)
TABLE 71
PATIENT REGISTRY SOFTWARE MARKET FOR HOSPITALS, BY REGION, 2023–2030 (USD MILLION)
TABLE 72
PATIENT REGISTRY SOFTWARE MARKET FOR CLINICS & OUTPATIENT SETTINGS, BY REGION, 2023–2030 (USD MILLION)
TABLE 73
PATIENT REGISTRY SOFTWARE MARKET FOR OTHER HEALTHCARE PROVIDERS, BY REGION, 2023–2030 (USD MILLION)
TABLE 74
PATIENT REGISTRY SOFTWARE MARKET FOR NONPROFIT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 75
PATIENT REGISTRY SOFTWARE MARKET FOR NONPROFIT REGISTRIES, BY REGION, 2023–2030 (USD MILLION)
TABLE 76
PATIENT REGISTRY SOFTWARE MARKET FOR MEDICAL SPECIALTY SOCIETIES, BY REGION, 2023–2030 (USD MILLION)
TABLE 77
PATIENT REGISTRY SOFTWARE MARKET FOR PATIENT ORGANIZATIONS, BY REGION, 2023–2030 (USD MILLION)
TABLE 78
PATIENT REGISTRY SOFTWARE MARKET FOR GOVERNMENT & THIRD-PARTY ADMINISTRATORS, BY REGION, 2023–2030 (USD MILLION)
TABLE 79
PATIENT REGISTRY SOFTWARE MARKET FOR OTHER END USERS, BY REGION, 2023–2030 (USD MILLION)
TABLE 80
PATIENT REGISTRY SOFTWARE MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 81
NORTH AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 82
NORTH AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 83
NORTH AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY USE CASE, 2023–2030 (USD MILLION)
TABLE 84
NORTH AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2023–2030 (USD MILLION)
TABLE 85
NORTH AMERICA: PATIENT REGISTRY SOFTWARE MARKET FOR DISEASE REGISTRIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 86
NORTH AMERICA: PATIENT REGISTRY SOFTWARE MARKET FOR PRODUCT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 87
NORTH AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT, 2023–2030 (USD MILLION)
TABLE 88
NORTH AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 89
NORTH AMERICA: PATIENT REGISTRY SOFTWARE MARKET FOR FOR-PROFIT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 90
NORTH AMERICA: PATIENT REGISTRY SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 91
NORTH AMERICA: PATIENT REGISTRY SOFTWARE MARKET FOR NONPROFIT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 92
US: PATIENT REGISTRY SOFTWARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 93
US: PATIENT REGISTRY SOFTWARE MARKET, BY USE CASE, 2023–2030 (USD MILLION)
TABLE 94
US: PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2023–2030 (USD MILLION)
TABLE 95
US: PATIENT REGISTRY SOFTWARE MARKET FOR DISEASE REGISTRIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 96
US: PATIENT REGISTRY SOFTWARE MARKET FOR PRODUCT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 97
US: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT, 2023–2030 (USD MILLION)
TABLE 98
US: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 99
US: PATIENT REGISTRY SOFTWARE MARKET FOR FOR-PROFIT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 100
US: PATIENT REGISTRY SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 101
US: PATIENT REGISTRY SOFTWARE MARKET FOR NONPROFIT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 102
CANADA: PATIENT REGISTRY SOFTWARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 103
CANADA: PATIENT REGISTRY SOFTWARE MARKET, BY USE CASE, 2023–2030 (USD MILLION)
TABLE 104
CANADA: PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2023–2030 (USD MILLION)
TABLE 105
CANADA: PATIENT REGISTRY SOFTWARE MARKET FOR DISEASE REGISTRIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 106
CANADA: PATIENT REGISTRY SOFTWARE MARKET FOR PRODUCT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 107
CANADA: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT, 2023–2030 (USD MILLION)
TABLE 108
CANADA: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 109
CANADA: PATIENT REGISTRY SOFTWARE MARKET FOR FOR-PROFIT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 110
CANADA: PATIENT REGISTRY SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 111
CANADA: PATIENT REGISTRY SOFTWARE MARKET FOR NONPROFIT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 112
EUROPE: PATIENT REGISTRY SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 113
EUROPE: PATIENT REGISTRY SOFTWARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 114
EUROPE: PATIENT REGISTRY SOFTWARE MARKET, BY USE CASE, 2023–2030 (USD MILLION)
TABLE 115
EUROPE: PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2023–2030 (USD MILLION)
TABLE 116
EUROPE: PATIENT REGISTRY SOFTWARE MARKET FOR DISEASE REGISTRIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 117
EUROPE: PATIENT REGISTRY SOFTWARE MARKET FOR PRODUCT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 118
EUROPE: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT, 2023–2030 (USD MILLION)
TABLE 119
EUROPE: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 120
EUROPE: PATIENT REGISTRY SOFTWARE MARKET FOR FOR-PROFIT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 121
EUROPE: PATIENT REGISTRY SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 122
EUROPE: PATIENT REGISTRY SOFTWARE MARKET FOR NONPROFIT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 123
UK: PATIENT REGISTRY SOFTWARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 124
UK: PATIENT REGISTRY SOFTWARE MARKET, BY USE CASE, 2023–2030 (USD MILLION)
TABLE 125
UK: PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2023–2030 (USD MILLION)
TABLE 126
UK: PATIENT REGISTRY SOFTWARE MARKET FOR DISEASE REGISTRIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 127
UK: PATIENT REGISTRY SOFTWARE MARKET FOR PRODUCT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 128
UK: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT, 2023–2030 (USD MILLION)
TABLE 129
UK: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 130
UK: PATIENT REGISTRY SOFTWARE MARKET FOR FOR-PROFIT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 131
UK: PATIENT REGISTRY SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 132
UK: PATIENT REGISTRY SOFTWARE MARKET FOR NONPROFIT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 133
GERMANY: PATIENT REGISTRY SOFTWARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 134
GERMANY: PATIENT REGISTRY SOFTWARE MARKET, BY USE CASE, 2023–2030 (USD MILLION)
TABLE 135
GERMANY: PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2023–2030 (USD MILLION)
TABLE 136
GERMANY: PATIENT REGISTRY SOFTWARE MARKET FOR DISEASE REGISTRIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 137
GERMANY: PATIENT REGISTRY SOFTWARE MARKET FOR PRODUCT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 138
GERMANY: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT, 2023–2030 (USD MILLION)
TABLE 139
GERMANY: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 140
GERMANY: PATIENT REGISTRY SOFTWARE MARKET FOR FOR-PROFIT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 141
GERMANY: PATIENT REGISTRY SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 142
GERMANY: PATIENT REGISTRY SOFTWARE MARKET FOR NONPROFIT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 143
FRANCE: PATIENT REGISTRY SOFTWARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 144
FRANCE: PATIENT REGISTRY SOFTWARE MARKET, BY USE CASE, 2023–2030 (USD MILLION)
TABLE 145
FRANCE: PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2023–2030 (USD MILLION)
TABLE 146
FRANCE: PATIENT REGISTRY SOFTWARE MARKET FOR DISEASE REGISTRIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 147
FRANCE: PATIENT REGISTRY SOFTWARE MARKET FOR PRODUCT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 148
FRANCE: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT, 2023–2030 (USD MILLION)
TABLE 149
FRANCE: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 150
FRANCE: PATIENT REGISTRY SOFTWARE MARKET FOR FOR-PROFIT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 151
FRANCE: PATIENT REGISTRY SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 152
FRANCE: PATIENT REGISTRY SOFTWARE MARKET FOR NONPROFIT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 153
ITALY: PATIENT REGISTRY SOFTWARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 154
ITALY: PATIENT REGISTRY SOFTWARE MARKET, BY USE CASE, 2023–2030 (USD MILLION)
TABLE 155
ITALY: PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2023–2030 (USD MILLION)
TABLE 156
ITALY: PATIENT REGISTRY SOFTWARE MARKET FOR DISEASE REGISTRIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 157
ITALY: PATIENT REGISTRY SOFTWARE MARKET FOR PRODUCT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 158
ITALY: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT, 2023–2030 (USD MILLION)
TABLE 159
ITALY: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 160
ITALY: PATIENT REGISTRY SOFTWARE MARKET FOR FOR-PROFIT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 161
ITALY: PATIENT REGISTRY SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 162
ITALY: PATIENT REGISTRY SOFTWARE MARKET FOR NONPROFIT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 163
SPAIN: PATIENT REGISTRY SOFTWARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 164
SPAIN: PATIENT REGISTRY SOFTWARE MARKET, BY USE CASE, 2023–2030 (USD MILLION)
TABLE 165
SPAIN: PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2023–2030 (USD MILLION)
TABLE 166
SPAIN: PATIENT REGISTRY SOFTWARE MARKET FOR DISEASE REGISTRIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 167
SPAIN: PATIENT REGISTRY SOFTWARE MARKET FOR PRODUCT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 168
SPAIN: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT, 2023–2030 (USD MILLION)
TABLE 169
SPAIN: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 170
SPAIN: PATIENT REGISTRY SOFTWARE MARKET FOR FOR-PROFIT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 171
SPAIN: PATIENT REGISTRY SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 172
SPAIN: PATIENT REGISTRY SOFTWARE MARKET FOR NONPROFIT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 173
REST OF EUROPE: PATIENT REGISTRY SOFTWARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 174
REST OF EUROPE: PATIENT REGISTRY SOFTWARE MARKET, BY USE CASE, 2023–2030 (USD MILLION)
TABLE 175
REST OF EUROPE: PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2023–2030 (USD MILLION)
TABLE 176
REST OF EUROPE: PATIENT REGISTRY SOFTWARE MARKET FOR DISEASE REGISTRIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 177
REST OF EUROPE: PATIENT REGISTRY SOFTWARE MARKET FOR PRODUCT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 178
REST OF EUROPE: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT, 2023–2030 (USD MILLION)
TABLE 179
REST OF EUROPE: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 180
REST OF EUROPE: PATIENT REGISTRY SOFTWARE MARKET FOR FOR-PROFIT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 181
REST OF EUROPE: PATIENT REGISTRY SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 182
REST OF EUROPE: PATIENT REGISTRY SOFTWARE MARKET FOR NONPROFIT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 183
ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 184
ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 185
ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET, BY USE CASE, 2023–2030 (USD MILLION)
TABLE 186
ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2023–2030 (USD MILLION)
TABLE 187
ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET FOR DISEASE REGISTRIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 188
ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET FOR PRODUCT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 189
ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT, 2023–2030 (USD MILLION)
TABLE 190
ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 191
ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET FOR FOR-PROFIT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 192
ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 193
ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET FOR NONPROFIT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 194
JAPAN: PATIENT REGISTRY SOFTWARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 195
JAPAN: PATIENT REGISTRY SOFTWARE MARKET, BY USE CASE, 2023–2030 (USD MILLION)
TABLE 196
JAPAN: PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2023–2030 (USD MILLION)
TABLE 197
JAPAN: PATIENT REGISTRY SOFTWARE MARKET FOR DISEASE REGISTRIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 198
JAPAN: PATIENT REGISTRY SOFTWARE MARKET FOR PRODUCT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 199
JAPAN: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT, 2023–2030 (USD MILLION)
TABLE 200
JAPAN: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 201
JAPAN: PATIENT REGISTRY SOFTWARE MARKET FOR FOR-PROFIT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 202
JAPAN: PATIENT REGISTRY SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 203
JAPAN: PATIENT REGISTRY SOFTWARE MARKET FOR NONPROFIT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 204
CHINA: PATIENT REGISTRY SOFTWARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 205
CHINA: PATIENT REGISTRY SOFTWARE MARKET, BY USE CASE, 2023–2030 (USD MILLION)
TABLE 206
CHINA: PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2023–2030 (USD MILLION)
TABLE 207
CHINA: PATIENT REGISTRY SOFTWARE MARKET FOR DISEASE REGISTRIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 208
CHINA: PATIENT REGISTRY SOFTWARE MARKET FOR PRODUCT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 209
CHINA: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT, 2023–2030 (USD MILLION)
TABLE 210
CHINA: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 211
CHINA: PATIENT REGISTRY SOFTWARE MARKET FOR FOR-PROFIT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 212
CHINA: PATIENT REGISTRY SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 213
CHINA: PATIENT REGISTRY SOFTWARE MARKET FOR NONPROFIT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 214
INDIA: PATIENT REGISTRY SOFTWARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 215
INDIA: PATIENT REGISTRY SOFTWARE MARKET, BY USE CASE, 2023–2030 (USD MILLION)
TABLE 216
INDIA: PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2023–2030 (USD MILLION)
TABLE 217
INDIA: PATIENT REGISTRY SOFTWARE MARKET FOR DISEASE REGISTRIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 218
INDIA: PATIENT REGISTRY SOFTWARE MARKET FOR PRODUCT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 219
INDIA: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT, 2023–2030 (USD MILLION)
TABLE 220
INDIA: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 221
INDIA: PATIENT REGISTRY SOFTWARE MARKET FOR FOR-PROFIT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 222
INDIA: PATIENT REGISTRY SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 223
INDIA: PATIENT REGISTRY SOFTWARE MARKET FOR NONPROFIT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 224
REST OF ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 225
REST OF ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET, BY USE CASE, 2023–2030 (USD MILLION)
TABLE 226
REST OF ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2023–2030 (USD MILLION)
TABLE 227
REST OF ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET FOR DISEASE REGISTRIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 228
REST OF ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET FOR PRODUCT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 229
REST OF ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT, 2023–2030 (USD MILLION)
TABLE 230
REST OF ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 231
REST OF ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET FOR FOR-PROFIT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 232
REST OF ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 233
REST OF ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET FOR NONPROFIT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 234
LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 235
LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 236
LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY USE CASE, 2023–2030 (USD MILLION)
TABLE 237
LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2023–2030 (USD MILLION)
TABLE 238
LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET FOR DISEASE REGISTRIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 239
LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET FOR PRODUCT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 240
LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT, 2023–2030 (USD MILLION)
TABLE 241
LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 242
LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET FOR FOR-PROFIT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 243
LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 244
LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET FOR NONPROFIT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 245
BRAZIL: PATIENT REGISTRY SOFTWARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 246
BRAZIL: PATIENT REGISTRY SOFTWARE MARKET, BY USE CASE, 2023–2030 (USD MILLION)
TABLE 247
BRAZIL: PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2023–2030 (USD MILLION)
TABLE 248
BRAZIL: PATIENT REGISTRY SOFTWARE MARKET FOR DISEASE REGISTRIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 249
BRAZIL: PATIENT REGISTRY SOFTWARE MARKET FOR PRODUCT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 250
BRAZIL: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT, 2023–2030 (USD MILLION)
TABLE 251
BRAZIL: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 252
BRAZIL: PATIENT REGISTRY SOFTWARE MARKET FOR FOR-PROFIT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 253
BRAZIL: PATIENT REGISTRY SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 254
BRAZIL: PATIENT REGISTRY SOFTWARE MARKET FOR NONPROFIT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 255
MEXICO: PATIENT REGISTRY SOFTWARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 256
MEXICO: PATIENT REGISTRY SOFTWARE MARKET, BY USE CASE, 2023–2030 (USD MILLION)
TABLE 257
MEXICO: PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2023–2030 (USD MILLION)
TABLE 258
MEXICO: PATIENT REGISTRY SOFTWARE MARKET FOR DISEASE REGISTRIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 259
MEXICO: PATIENT REGISTRY SOFTWARE MARKET FOR PRODUCT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 260
MEXICO: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT, 2023–2030 (USD MILLION)
TABLE 261
MEXICO: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 262
MEXICO: PATIENT REGISTRY SOFTWARE MARKET FOR FOR-PROFIT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 263
MEXICO: PATIENT REGISTRY SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 264
MEXICO: PATIENT REGISTRY SOFTWARE MARKET FOR NONPROFIT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 265
REST OF LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 266
REST OF LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY USE CASE, 2023–2030 (USD MILLION)
TABLE 267
REST OF LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2023–2030 (USD MILLION)
TABLE 268
REST OF LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET FOR DISEASE REGISTRIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 269
REST OF LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET FOR PRODUCT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 270
REST OF LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT, 2023–2030 (USD MILLION)
TABLE 271
REST OF LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 272
REST OF LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET FOR FOR-PROFIT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 273
REST OF LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 274
REST OF LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET FOR NONPROFIT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 275
MIDDLE EAST & AFRICA: PATIENT REGISTRY SOFTWARE MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 276
MIDDLE EAST & AFRICA: PATIENT REGISTRY SOFTWARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 277
MIDDLE EAST & AFRICA: PATIENT REGISTRY SOFTWARE MARKET, BY USE CASE, 2023–2030 (USD MILLION)
TABLE 278
MIDDLE EAST & AFRICA: PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2023–2030 (USD MILLION)
TABLE 279
MIDDLE EAST & AFRICA: PATIENT REGISTRY SOFTWARE MARKET FOR DISEASE REGISTRIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 280
MIDDLE EAST & AFRICA: PATIENT REGISTRY SOFTWARE MARKET FOR PRODUCT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 281
MIDDLE EAST & AFRICA: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT, 2023–2030 (USD MILLION)
TABLE 282
MIDDLE EAST & AFRICA: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 283
MIDDLE EAST & AFRICA: PATIENT REGISTRY SOFTWARE MARKET FOR FOR-PROFIT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 284
MIDDLE EAST & AFRICA: PATIENT REGISTRY SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 285
MIDDLE EAST & AFRICA: PATIENT REGISTRY SOFTWARE MARKET FOR NONPROFIT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 286
GCC COUNTRIES: PATIENT REGISTRY SOFTWARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 287
GCC COUNTRIES: PATIENT REGISTRY SOFTWARE MARKET, BY USE CASE, 2023–2030 (USD MILLION)
TABLE 288
GCC COUNTRIES: PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2023–2030 (USD MILLION)
TABLE 289
GCC COUNTRIES: PATIENT REGISTRY SOFTWARE MARKET FOR DISEASE REGISTRIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 290
GCC COUNTRIES: PATIENT REGISTRY SOFTWARE MARKET FOR PRODUCT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 291
GCC COUNTRIES: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT, 2023–2030 (USD MILLION)
TABLE 292
GCC COUNTRIES: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 293
GCC COUNTRIES: PATIENT REGISTRY SOFTWARE MARKET FOR FOR-PROFIT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 294
GCC COUNTRIES: PATIENT REGISTRY SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 295
GCC COUNTRIES: PATIENT REGISTRY SOFTWARE MARKET FOR NONPROFIT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 296
REST OF MIDDLE EAST & AFRICA: PATIENT REGISTRY SOFTWARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 297
REST OF MIDDLE EAST & AFRICA: PATIENT REGISTRY SOFTWARE MARKET, BY USE CASE, 2023–2030 (USD MILLION)
TABLE 298
REST OF MIDDLE EAST & AFRICA: PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2023–2030 (USD MILLION)
TABLE 299
REST OF MIDDLE EAST & AFRICA: PATIENT REGISTRY SOFTWARE MARKET FOR DISEASE REGISTRIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 300
REST OF MIDDLE EAST & AFRICA: PATIENT REGISTRY SOFTWARE MARKET FOR PRODUCT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 301
REST OF MIDDLE EAST & AFRICA: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT, 2023–2030 (USD MILLION)
TABLE 302
REST OF MIDDLE EAST & AFRICA: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 303
REST OF MIDDLE EAST & AFRICA: PATIENT REGISTRY SOFTWARE MARKET FOR FOR-PROFIT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 304
REST OF MIDDLE EAST & AFRICA: PATIENT REGISTRY SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 305
REST OF MIDDLE EAST & AFRICA: PATIENT REGISTRY SOFTWARE MARKET FOR NONPROFIT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 306
OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN PATIENT REGISTRY SOFTWARE MARKET, JANUARY 2022–JUNE 2025
TABLE 307
PATIENT REGISTRY SOFTWARE MARKET: DEGREE OF COMPETITION
TABLE 308
PATIENT REGISTRY SOFTWARE MARKET: REGION FOOTPRINT
TABLE 309
PATIENT REGISTRY SOFTWARE MARKET: PRODUCT FOOTPRINT
TABLE 310
PATIENT REGISTRY SOFTWARE MARKET: USE CASE FOOTPRINT
TABLE 311
PATIENT REGISTRY SOFTWARE MARKET: REGISTRY TYPE FOOTPRINT
TABLE 312
PATIENT REGISTRY SOFTWARE MARKET: DEPLOYMENT FOOTPRINT
TABLE 313
PATIENT REGISTRY SOFTWARE MARKET: END-USER FOOTPRINT
TABLE 314
PATIENT REGISTRY SOFTWARE MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
TABLE 315
PATIENT REGISTRY SOFTWARE MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS, BY PRODUCT AND REGION
TABLE 316
PATIENT REGISTRY SOFTWARE MARKET: PRODUCT LAUNCHES, APPROVALS, UPGRADES, AND ENHANCEMENTS, JANUARY 2022–JUNE 2025
TABLE 317
PATIENT REGISTRY SOFTWARE MARKET: DEALS, JANUARY 2022–JUNE 2025
TABLE 318
PATIENT REGISTRY SOFTWARE MARKET: OTHER DEVELOPMENTS, JANUARY 2022–JUNE 2025
TABLE 319
IBM: COMPANY OVERVIEW
TABLE 320
IBM: PRODUCTS OFFERED
TABLE 321
IBM: PRODUCT ENHANCEMENTS, JANUARY 2022–JUNE 2025
TABLE 322
IQVIA HOLDINGS INC.: COMPANY OVERVIEW
TABLE 323
IQVIA HOLDINGS INC.: PRODUCTS OFFERED
TABLE 324
IQVIA HOLDINGS INC.: DEALS, JANUARY 2022–JUNE 2025
TABLE 325
HEALTH CATALYST, INC.: COMPANY OVERVIEW
TABLE 326
HEALTH CATALYST, INC.: PRODUCTS OFFERED
TABLE 327
HEALTH CATALYST, INC.: PRODUCT APPROVALS, JANUARY 2022–JUNE 2025
TABLE 328
HEALTH CATALYST, INC.: DEALS, JANUARY 2022–JUNE 2025
TABLE 329
HEALTH CATALYST, INC.: OTHER DEVELOPMENTS, JANUARY 2022–JUNE 2025
TABLE 330
ORACLE: COMPANY OVERVIEW
TABLE 331
ORACLE: PRODUCTS OFFERED
TABLE 332
ORACLE: DEALS, JANUARY 2022–JUNE 2025
TABLE 333
UNITEDHEALTH GROUP: COMPANY OVERVIEW
TABLE 334
UNITEDHEALTH GROUP: PRODUCTS OFFERED
TABLE 335
UNITEDHEALTH GROUP: DEALS, JANUARY 2022–JUNE 2025
TABLE 336
CONDUENT INCORPORATED: COMPANY OVERVIEW
TABLE 337
CONDUENT INCORPORATED: PRODUCTS OFFERED
TABLE 338
CONDUENT INCORPORATED: DEALS, JANUARY 2022–JUNE 2025
TABLE 339
ELEKTA: COMPANY OVERVIEW
TABLE 340
ELEKTA: PRODUCTS OFFERED
TABLE 341
ELEKTA: DEALS, JANUARY 2022–JUNE 2025
TABLE 342
NEC CORPORATION (NEC SOFTWARE SOLUTIONS UK LIMITED): COMPANY OVERVIEW
TABLE 343
NEC CORPORATION (NEC SOFTWARE SOLUTIONS UK LIMITED): PRODUCTS OFFERED
TABLE 344
DASSAULT SYSTÈMES (MEDIDATA): COMPANY OVERVIEW
TABLE 345
DASSAULT SYSTÈMES (MEDIDATA): PRODUCTS OFFERED
TABLE 346
DASSAULT SYSTÈMES (MEDIDATA): PRODUCT LAUNCHES, JANUARY 2022–JUNE 2025
TABLE 347
DASSAULT SYSTÈMES (MEDIDATA): DEALS, JANUARY 2022–JUNE 2025
TABLE 348
EVIDENTIQ (DECIMA SOFTWARE INC.): COMPANY OVERVIEW
TABLE 349
EVIDENTIQ (DECIMA SOFTWARE INC.): PRODUCTS OFFERED
TABLE 350
EVIDENTIQ (DECIMA SOFTWARE INC.): DEALS, JANUARY 2022–JUNE 2025
TABLE 351
MRO (FIGMD, INC.): COMPANY OVERVIEW
TABLE 352
MRO (FIGMD, INC.): PRODUCTS OFFERED
TABLE 353
MRO (FIGMD, INC.): DEALS, JANUARY 2022–JUNE 2025
TABLE 354
MRO (FIGMD, INC.): OTHER DEVELOPMENTS, JANUARY 2022–JUNE 2025
TABLE 355
IMAGETREND: COMPANY OVERVIEW
TABLE 356
IMAGETREND: PRODUCTS OFFERED
TABLE 357
IMAGETREND: PRODUCT UPGRADES, JANUARY 2022–JUNE 2025
TABLE 358
IMAGETREND: DEALS, JANUARY 2022–JUNE 2025
TABLE 359
GLOBAL VISION TECHNOLOGIES, INC.: COMPANY OVERVIEW
TABLE 360
GLOBAL VISION TECHNOLOGIES, INC.: PRODUCTS OFFERED
TABLE 361
GLOBAL VISION TECHNOLOGIES, INC.: OTHER DEVELOPMENTS , JANUARY 2022–JUNE 2025
TABLE 362
SYNEOS HEALTH: COMPANY OVERVIEW
TABLE 363
SYNEOS HEALTH: PRODUCTS OFFERED
TABLE 364
SYNEOS HEALTH: DEALS, JANUARY 2022–JUNE 2025
TABLE 365
VERADIGM LLC: COMPANY OVERVIEW
TABLE 366
VERADIGM LLC: PRODUCTS OFFERED
TABLE 367
VERADIGM LLC: PRODUCT LAUNCHES, JANUARY 2022–JUNE 2025
TABLE 368
VERADIGM LLC: DEALS, JANUARY 2022–JUNE 2025
TABLE 369
ESO: COMPANY OVERVIEW
TABLE 370
ESO: PRODUCTS OFFERED
TABLE 371
ESO: DEALS, JANUARY 2022–JUNE 2025
TABLE 372
ORDINAL DATA, INC.: COMPANY OVERVIEW
TABLE 373
ORDINAL DATA, INC.: PRODUCTS OFFERED
TABLE 374
CEDARON MEDICAL: COMPANY OVERVIEW
TABLE 375
CEDARON MEDICAL: PRODUCTS OFFERED
TABLE 376
FIVOS HEALTH: COMPANY OVERVIEW
TABLE 377
FIVOS HEALTH: PRODUCTS OFFERED
TABLE 378
FIVOS HEALTH: DEALS, JANUARY 2022–JUNE 2025
TABLE 379
ACROSS HEALTHCARE: COMPANY OVERVIEW
TABLE 380
ACROSS HEALTHCARE: PRODUCTS OFFERED
TABLE 381
ACROSS HEALTHCARE: DEALS, JANUARY 2022–JUNE 2025
LIST OF FIGURES
FIGURE 1
PATIENT REGISTRY SOFTWARE MARKET SEGMENTATION & REGIONAL SCOPE
FIGURE 2
RESEARCH DESIGN
FIGURE 3
PRIMARY SOURCES
FIGURE 4
INSIGHTS FROM INDUSTRY EXPERTS
FIGURE 5
BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 6
RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
FIGURE 7
SUPPLY-SIDE MARKET ESTIMATION
FIGURE 8
PATIENT REGISTRY SOFTWARE MARKET: REVENUE ESTIMATION APPROACH
FIGURE 9
BOTTOM-UP APPROACH: END-USER SPENDING ON PATIENT REGISTRY SOFTWARE
FIGURE 10
CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2025–2030)
FIGURE 11
CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 12
TOP-DOWN APPROACH
FIGURE 13
DATA TRIANGULATION METHODOLOGY
FIGURE 14
PATIENT REGISTRY SOFTWARE MARKET, BY PRODUCT, 2025 VS. 2030 (USD MILLION)
FIGURE 15
PATIENT REGISTRY SOFTWARE MARKET, BY USE CASE, 2025 VS. 2030 (USD MILLION)
FIGURE 16
PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2025 VS. 2030 (USD MILLION)
FIGURE 17
PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT, 2025 VS. 2030 (USD MILLION)
FIGURE 18
PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
FIGURE 19
PATIENT REGISTRY SOFTWARE MARKET: GEOGRAPHICAL SNAPSHOT
FIGURE 20
GROWING DEMAND FOR REAL-WORLD EVIDENCE, INTEROPERABILITY, AND REGULATORY COMPLIANCE TO DRIVE MARKET GROWTH
FIGURE 21
SITE-BASED/CLINICAL DATA (PROVIDER-RECORDED) REGISTRIES IN NORTH AMERICA TO ACCOUNT FOR LARGEST MARKET SHARE IN 2025
FIGURE 22
CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
FIGURE 23
GROWTH RATES OF EMERGING ECONOMIES TO BE HIGHER THAN THOSE OF DEVELOPED ECONOMIES DURING FORECAST PERIOD
FIGURE 24
PATIENT REGISTRY SOFTWARE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 25
TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
FIGURE 26
PATIENT REGISTRY SOFTWARE MARKET: ECOSYSTEM ANALYSIS
FIGURE 27
PATIENT REGISTRY SOFTWARE MARKET: VALUE CHAIN ANALYSIS
FIGURE 28
PATIENT REGISTRY SOFTWARE MARKET: PORTER’S FIVE FORCES ANALYSIS
FIGURE 29
GLOBAL PATENT PUBLICATION TRENDS IN PATIENT REGISTRY SOFTWARE, 2015–2025
FIGURE 30
JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR “PATIENT REGISTRY SOFTWARE” PATENTS (JANUARY 2015–JUNE 2025)
FIGURE 31
MAJOR PATENTS IN PATIENT REGISTRY SOFTWARE MARKET (JANUARY 2015–JUNE 2025)
FIGURE 32
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS
FIGURE 33
KEY BUYING CRITERIA FOR TOP THREE END USERS
FIGURE 35
MARKET POTENTIAL OF AI/GENERATIVE AI IN ENHANCING PATIENT REGISTRY SOFTWARE ACROSS INDUSTRIES
FIGURE 36
IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS
FIGURE 37
NORTH AMERICA: PATIENT REGISTRY SOFTWARE MARKET SNAPSHOT
FIGURE 38
EUROPE: PATIENT REGISTRY SOFTWARE MARKET SNAPSHOT
FIGURE 39
ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET SNAPSHOT
FIGURE 40
REVENUE ANALYSIS OF KEY PLAYERS IN PATIENT REGISTRY SOFTWARE MARKET, 2020–2024 (USD MILLION)
FIGURE 41
MARKET SHARE ANALYSIS OF KEY PLAYERS IN PATIENT REGISTRY SOFTWARE MARKET (2024)
FIGURE 42
PATIENT REGISTRY SOFTWARE MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
FIGURE 43
PATIENT REGISTRY SOFTWARE MARKET: COMPANY FOOTPRINT
FIGURE 44
PATIENT REGISTRY SOFTWARE MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
FIGURE 45
EV/EBITDA OF KEY VENDORS
FIGURE 46
YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
FIGURE 47
PATIENT REGISTRY SOFTWARE MARKET: BRAND/SOFTWARE COMPARATIVE ANALYSIS
FIGURE 48
IBM: COMPANY SNAPSHOT (2024)
FIGURE 49
IQVIA HOLDINGS INC.: COMPANY SNAPSHOT (2024)
FIGURE 50
HEALTH CATALYST, INC.: COMPANY SNAPSHOT (2024)
FIGURE 51
ORACLE: COMPANY SNAPSHOT (2024)
FIGURE 52
UNITEDHEALTH GROUP: COMPANY SNAPSHOT (2024)
FIGURE 53
CONDUENT INCORPORATED: COMPANY SNAPSHOT (2024)
FIGURE 54
ELEKTA: COMPANY SNAPSHOT (2024)
FIGURE 55
NEC CORPORATION (NEC SOFTWARE SOLUTIONS UK LIMITED): COMPANY SNAPSHOT
FIGURE 56
DASSAULT SYSTÈMES (MEDIDATA): COMPANY SNAPSHOT (2024)
FIGURE 57
VERADIGM LLC: COMPANY SNAPSHOT (2022)
Methodology
The study involved five major activities to estimate the current size of the patient registry software market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.
Secondary Research
This research study involved the wide use of secondary sources, directories, and databases such as Dun & Bradstreet, Bloomberg Business, and Factiva; white papers, annual reports, and companies’ house documents; investor presentations; and the SEC filings of companies. The market for companies providing patient registry software solutions is assessed using secondary data from both paid and free sources. This involves analyzing the product portfolios of major players in the industry and evaluating these companies based on their performance and quality. Various resources were utilized in the secondary research process to gather information for this study. The sources include annual reports, press releases, investor presentations, white papers, academic journals, certified publications, articles by recognized authors, directories, and databases.
The secondary research process involved referring to various secondary sources to identify and collect information related to the study. These sources included annual reports, press releases, investor presentations of patient registry software vendors, forums, certified publications, and whitepapers. The secondary research was used to obtain critical information on the industry’s value chain, the total pool of key players, market classification, and segmentation from the market and technology-oriented perspectives.
Primary Research
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources are mainly industry experts from the core and related industries and preferred suppliers, manufacturers, distributors, technology developers, researchers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify the critical qualitative and quantitative information as well as assess prospects.
Primary research was conducted to identify segmentation types, industry trends, key players, and key market dynamics such as drivers, restraints, opportunities, challenges, industry trends, and strategies adopted by key players.
After completing the market engineering process, which includes calculations for market statistics, market breakdown, size estimations, forecasting, and data triangulation, extensive primary research was conducted. This research aimed to gather information and verify the critical numbers obtained during the market analysis. Additionally, primary research was conducted to identify different types of market segmentation, analyze industry trends, evaluate the competitive landscape of patient registry software solutions offered by various players, and understand key market dynamics such as drivers, restraints, opportunities, challenges, industry trends, and strategies employed by key market participants.
In the complete market engineering process, the top-down and bottom-up approaches and several data triangulation methods were extensively used to perform the market estimation and market forecasting for the overall market segments and subsegments listed in this report. Extensive qualitative and quantitative analysis was performed on the complete market engineering process to list the key information/insights throughout the report.
Breakdown of Primary Respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
The market size estimates and forecasts provided in this study are derived through a mix of the bottom-up approach (revenue share analysis of leading players) and top-down approach (assessment of utilization/adoption/penetration trends, by product, functionality, registry type, software, pricing model, deployment model, database type, end user, and region).
Data Triangulation
After arriving at the overall market size using the market size estimation processes, the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from the demand and supply sides of the patient registry software market.
Market Definition
Patient registry software is a digital tool designed to systematically collect, store, manage, and analyze patient data related to specific diseases, conditions, treatments, or outcomes. This software enables real-world evidence generation, supports research efforts, and improves clinical decision-making. It allows for the long-term tracking of patient outcomes, enhances population health management, and aids in ensuring regulatory compliance and implementing quality improvement initiatives.
Stakeholders
- Patient Registry Software Vendors
- Government Bodies
- Healthcare Providers
- Clinical/Physician Centers
- Healthcare Professionals
- Health IT Service Providers
- Healthcare Associations/Institutes
- Venture Capitalists
- Maintenance and Support Service Providers
- Integration Service Providers
- Healthcare Payers
- Advocacy Groups
- Investors and Financial Institutions
- Industry Associations and Trade Groups
Report Objectives
- To define, describe, and forecast the global patient registry software market by product, use case, registry type, deployment model, end user, and region
- To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, opportunities, and challenges)
- To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall patient registry software market
- To assess the patient registry software market with regard to Porter’s Five Forces, regulatory landscape, value chain, ecosystem map, patent analysis, and key stakeholders’ buying criteria
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the patient registry software market with respect to five main regions: North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
- To profile the key players in the patient registry software market and comprehensively analyze their core competencies and market shares
- To track and analyze competitive developments such as agreements, partnerships, and acquisitions; expansions; product launches & enhancements; and R&D activities in the patient registry software market
Key Questions Addressed by the Report
Which are the top industry players in the global patient registry market?
Prominent players in the patient registry market include IBM (US), IQVIA Holdings Inc. (US), Health Catalyst Inc. (US), Oracle (US), UnitedHealth Group (US), Conduent Inc. (US), Elekta (Sweden), Dassault Systèmes (France), and NEC Corporation (Japan).
Which registry type has been included in the patient registry market report?
This report includes disease registries (diabetes, cardiovascular, cancer, rare disease, asthma, chronic kidney, orthopedic, immunization, birth defect, and other disease registries) and product registries (medical device and drug registries).
Which geographical region is dominating the global patient registry market?
The patient registry market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America holds the largest share, while Asia Pacific is expected to register the highest growth during the forecast period.
Which end-user segments have been included in the patient registry market report?
End users include profit registries (pharmaceutical, biotechnology, and medical device companies, payers, healthcare providers), non-profit registries (medical specialty societies, patient organizations), government & third-party administrators, and other end users.
What is the total CAGR expected to be recorded for the patient registry market during 2025–2030?
The global patient registry market is expected to record a CAGR of 9.8% during the forecast period from 2025 to 2030.
Personalize This Research
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
Let Us Help You
- What are the Known and Unknown Adjacencies Impacting the Patient Registry Software Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
Custom Market Research Services
We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements
Get 10% Free Customisation
Before You Go
Expand Beyond Patient Registry Software Market
Explore the top 20 industries influencing your market growth
Human and AI Powered Market Intelligence
Find Untapped Markets
Growth opportunities and latent adjacency in Patient Registry Software Market